Orthopedic Biomaterial Market Share Analysis
Knee osteoarthritis stands as a prevalent and impactful ailment, emerging as a leading cause of disability, particularly among the elderly. The surge in the overall age of the population has given rise to an escalating prevalence of knee osteoarthritis, a condition that affects individuals with various health challenges such as obesity, diabetes, hypertension, renal failure, cardiovascular diseases, gastrointestinal bleeding, depression, and joint trauma resulting from repetitive movements.
Data from the Arthritis Foundation highlights the magnitude of the issue, indicating that osteoarthritis, the most common type of arthritis, afflicts over 30 million Americans. Specifically, among those aged 60 and above, approximately 13% of women and 10% of men contend with symptomatic knee osteoarthritis. Notably, the prevalence of osteoarthritis tends to be higher in women compared to men. Contributing factors to the increasing incidence of osteoarthritis and its counterpart, osteoporosis, among the younger population include smoking, injuries, poor nutrition, and evolving lifestyles.
In response to this growing health concern, there is an imperative need for swift and accurate disease diagnosis to facilitate timely and effective intervention. Viscosupplementation, a medical procedure involving the injection of a lubricating fluid like hyaluronic acid into joints to alleviate symptoms of osteoarthritis, is poised to play a pivotal role in addressing this need. As the prevalence of knee osteoarthritis continues to escalate, the utilization of viscosupplementation is anticipated to witness substantial growth throughout the forecast period.
The multifaceted nature of osteoarthritis, with its connections to various health conditions and lifestyle factors, underscores the importance of comprehensive healthcare strategies. As individuals face increased risks due to a combination of factors, including age-related degeneration, chronic diseases, and lifestyle choices, the healthcare landscape must adapt to provide effective solutions.
Moreover, the demand for faster and more accurate diagnostic methods is becoming increasingly apparent. The ability to identify and address knee osteoarthritis promptly is crucial for mitigating its impact on individuals' quality of life and preventing further complications. Viscosupplementation emerges as a promising avenue in this regard, offering a minimally invasive approach to managing symptoms and enhancing joint function.
The escalating prevalence of knee osteoarthritis necessitates a comprehensive and proactive approach to healthcare. With a substantial portion of the population, particularly the elderly, grappling with this condition, the adoption of advanced medical interventions like viscosupplementation becomes pivotal. The trajectory of healthcare must align with the evolving landscape of health challenges, ensuring that innovative and effective solutions are readily available to address the intricate interplay of factors contributing to knee osteoarthritis.
Report Attribute/Metric |
Details |
Base Year For Estimation |
2021 Forecast Period 2022-2030 Historical Data 2019-2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Material Class,Application, and End Use Geographies Covered Americas, Europe, Asia-Pacific, Middle East & Africa Key Vendors Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith& Nephew plc (UK),3M (US), NobelBiocare Services AG(Switzerland), Medtronic plc (Ireland), DePuy Synthes (US). Key Market Opportunities Technological advancement in the medical implant market, Adoption of growth strategies by key players. Key Market Drivers Growing demand for next-generation orthopedic biomaterials, increasing older population leading to increase in patient population, rising prevalence of orthopedic diseases. |
Historical Data |
2019-2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Material Class,Application, and End Use Geographies Covered Americas, Europe, Asia-Pacific, Middle East & Africa Key Vendors Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith& Nephew plc (UK),3M (US), NobelBiocare Services AG(Switzerland), Medtronic plc (Ireland), DePuy Synthes (US). Key Market Opportunities Technological advancement in the medical implant market, Adoption of growth strategies by key players. Key Market Drivers Growing demand for next-generation orthopedic biomaterials, increasing older population leading to increase in patient population, rising prevalence of orthopedic diseases. |
Forecast Period |
2022-2030 Historical Data 2019-2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Material Class,Application, and End Use Geographies Covered Americas, Europe, Asia-Pacific, Middle East & Africa Key Vendors Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith& Nephew plc (UK),3M (US), NobelBiocare Services AG(Switzerland), Medtronic plc (Ireland), DePuy Synthes (US). Key Market Opportunities Technological advancement in the medical implant market, Adoption of growth strategies by key players. Key Market Drivers Growing demand for next-generation orthopedic biomaterials, increasing older population leading to increase in patient population, rising prevalence of orthopedic diseases. |
Growth Rate |
10.20% (2022-2030 Base Year 2021 Forecast Period 2022-2030 Historical Data 2019-2020 Forecast Units Value (USD Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product, Material Class,Application, and End Use Geographies Covered Americas, Europe, Asia-Pacific, Middle East & Africa Key Vendors Stryker (US), CoorsTek Inc (US), Zimmer Biomet Holdings Inc (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith& Nephew plc (UK),3M (US), NobelBiocare Services AG(Switzerland), Medtronic plc (Ireland), DePuy Synthes (US). Key Market Opportunities Technological advancement in the medical implant market, Adoption of growth strategies by key players. Key Market Drivers Growing demand for next-generation orthopedic biomaterials, increasing older population leading to increase in patient population, rising prevalence of orthopedic diseases. |